Tinnitus reduction after active bone-conduction implantation in patients with single-sided deafness: a prospective multicenter study.

Jungho HaMoo Kyun ParkShi Nae ParkHyong-Ho ChoJae Young ChoiChi Kyou LeeIl-Woo LeeIl Joon MoonJae Yun JungJinsei JungKyu-Yup LeeJeong-Hoon OhHong Ju ParkJae-Hyun SeoJae-Jin SongHantai KimJeong Hun JangYun-Hoon Choung

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)

The Bonebridge BCI602 effectively reduced tinnitus in SSD patients, particularly in those with residual hearing. Subjective satisfaction improved in both the tinnitus and non-tinnitus groups. These findings demonstrate the therapeutic potential of BCI for managing SSD and associated tinnitus.

Keyphrases

hearing loss
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
bone mineral density
patient reported outcomes
physical activity
postmenopausal women